Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

The mutated hairless gene causes hair loss by acting as a new type of corepressor affecting thyroid hormone receptors.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

Fibromodulin might help reduce scarring if increased in adult wounds like in fetal skin that heals without scars.

Estrogen therapy can reduce skin aging but has cancer risks.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Lampreys have a functional vitamin D receptor that may help detoxify harmful substances.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Human liver cells stick to hair protein materials mainly through the liver's asialoglycoprotein receptor.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Basal cell carcinomas have much higher levels of Vitamin D3 receptors compared to healthy skin.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The ITGB6 gene is important for tissue repair and hair growth, and mutations can lead to enamel defects and other health issues.

Mutations in certain receptors can cause diseases and offer new treatment options.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Finasteride may improve prostate cancer treatment outcomes.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Dutasteride and finasteride affect different cell types differently.